Latest Stonepine Capital Management, LLC Stock Portfolio
Stonepine Capital Management, LLC Performance:
2024 Q3: 23.21%YTD: 48.76%2023: -9.22%
Performance for 2024 Q3 is 23.21%, and YTD is 48.76%, and 2023 is -9.22%.
About Stonepine Capital Management, LLC and 13F Hedge Fund Stock Holdings
Stonepine Capital Management, LLC is a hedge fund based in BEND, OR. On 08-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $271.5 Millions. In it's latest 13F Holdings report, Stonepine Capital Management, LLC reported an equity portfolio of $158.2 Millions as of 30 Sep, 2024.
The top stock holdings of Stonepine Capital Management, LLC are ADMA, EOLS, . The fund has invested 23.6% of it's portfolio in ADMA BIOLOGICS INC and 14% of portfolio in EVOLUS INC.
The fund managers got completely rid off ALIMERA SCIENCES INC (ALIM), AURINIA PHARMACEUTICALS INC (AUPH) and KIORA PHARMACEUTICALS INC (KPRX) stocks. They significantly reduced their stock positions in REVANCE THERAPEUTICS INC (RVNC), XOMA CORP (XOMA) and MILESTONE PHARMACEUTICALS IN (MIST). Stonepine Capital Management, LLC opened new stock positions in JAZZ PHARMACEUTICALS PLC US LISTED (JAZZ), ROYALTY PHARMA PLC (RPRX) and ZEVRA THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to ACADIA PHARMACEUTICALS INC (ACAD), IRONWOOD PHARMACEUTICALS INC (IRWD) and OPTINOSE INC (OPTN).
The top stock holdings of Stonepine Capital Management, LLC are ADMA, EOLS, . The fund has invested 23.6% of it's portfolio in ADMA BIOLOGICS INC and 14% of portfolio in EVOLUS INC.
The fund managers got completely rid off ALIMERA SCIENCES INC (ALIM), AURINIA PHARMACEUTICALS INC (AUPH) and KIORA PHARMACEUTICALS INC (KPRX) stocks. They significantly reduced their stock positions in REVANCE THERAPEUTICS INC (RVNC), XOMA CORP (XOMA) and MILESTONE PHARMACEUTICALS IN (MIST). Stonepine Capital Management, LLC opened new stock positions in JAZZ PHARMACEUTICALS PLC US LISTED (JAZZ), ROYALTY PHARMA PLC (RPRX) and ZEVRA THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to ACADIA PHARMACEUTICALS INC (ACAD), IRONWOOD PHARMACEUTICALS INC (IRWD) and OPTINOSE INC (OPTN).
Stonepine Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Stonepine Capital Management, LLC made a return of 23.21% in the last quarter. In trailing 12 months, it's portfolio return was 55.18%.
New Buys
| Ticker | $ Bought |
|---|---|
| jazz pharmaceuticals plc us listed | 6,127,550 |
| royalty pharma plc | 5,997,480 |
| zevra therapeutics inc | 4,858,000 |
| verastem inc | 3,917,760 |
| urogen pharma ltd | 3,560,380 |
| establishment labs holdings | 3,245,250 |
| day one biopharmaceuticals i | 2,865,050 |
| indivior plc | 2,632,500 |
New stocks bought by Stonepine Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| acadia pharmaceuticals inc | 3,837 |
| ironwood pharmaceuticals inc | 1,982 |
| optinose inc | 142 |
| scpharmaceuticals inc | 84.7 |
| tela bio inc | 77.42 |
| surrozen inc | 66.45 |
| exagen inc | 48.98 |
| kezar life sciences inc | 41.97 |
Additions to existing portfolio by Stonepine Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| revance therapeutics inc | -70.71 |
| xoma corp | -22.00 |
| milestone pharmaceuticals in | -19.32 |
| evolus inc | -17.36 |
| galapagos nv | -1.31 |
Stonepine Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| alimera sciences inc | -19,525,700 |
| aurinia pharmaceuticals inc | -1,713,000 |
| kiora pharmaceuticals inc | -840,000 |
| eton pharmaceuticals inc | -361,900 |
Stonepine Capital Management, LLC got rid off the above stocks
Sector Distribution
Stonepine Capital Management, LLC has about 86.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 86.2 |
| Others | 13.8 |
Market Cap. Distribution
Stonepine Capital Management, LLC has about 3.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 29.6 |
| MID-CAP | 29.4 |
| MICRO-CAP | 19.2 |
| UNALLOCATED | 13.8 |
| NANO-CAP | 4.2 |
| LARGE-CAP | 3.8 |
Stocks belong to which Index?
About 69.3% of the stocks held by Stonepine Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 69.3 |
| Others | 30.7 |
Stonepine Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Stonepine Capital Management, LLC
Stonepine Capital Management, LLC has 38 stocks in it's portfolio. About 69.2% of the portfolio is in top 10 stocks. OPTN proved to be the most loss making stock for the portfolio. ADMA was the most profitable stock for Stonepine Capital Management, LLC last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADMA | adma biologics inc | 23.62 | 1,870,000 | 37,381,300 | unchanged | 0.00 | ||
Historical Trend of ADMA BIOLOGICS INC Position Held By Stonepine Capital Management, LLCWhat % of Portfolio is ADMA?:Number of ADMA shares held:Change in No. of Shares Held: | ||||||||
| EOLS | evolus inc | 14.02 | 1,369,820 | 22,191,100 | reduced | -17.36 | ||
| galapagos nv | 8.71 | 478,659 | 13,780,600 | reduced | -1.31 | |||
| JAZZ | jazz pharmaceuticals plc us listed | 3.87 | 55,000 | 6,127,550 | new | |||
| RPRX | royalty pharma plc | 3.79 | 212,000 | 5,997,480 | new | |||
| XOMA | xoma corp | 3.27 | 195,096 | 5,166,140 | reduced | -22.00 | ||
| RIGL | rigel pharmaceuticals inc | 3.16 | 309,100 | 5,001,240 | added | 1.34 | ||
| zevra therapeutics inc | 3.07 | 700,000 | 4,858,000 | new | ||||
| ANIK | anika therapeutics inc | 2.96 | 189,308 | 4,675,910 | added | 14.46 | ||
| RVNC | revance therapeutics inc | 2.69 | 820,000 | 4,255,800 | reduced | -70.71 | ||
| IRWD | ironwood pharmaceuticals inc | 2.60 | 1,000,000 | 4,120,000 | added | 1,982 | ||
| VSTM | verastem inc | 2.48 | 1,310,290 | 3,917,760 | new | |||
| OPTN | optinose inc | 2.41 | 5,688,590 | 3,811,360 | added | 142 | ||
| URGN | urogen pharma ltd | 2.25 | 280,345 | 3,560,380 | new | |||
| SCPH | scpharmaceuticals inc | 2.24 | 778,874 | 3,551,660 | added | 84.7 | ||
| ESTA | establishment labs holdings | 2.05 | 75,000 | 3,245,250 | new | |||
| ACAD | acadia pharmaceuticals inc | 1.91 | 196,895 | 3,028,240 | added | 3,837 | ||
| DAWN | day one biopharmaceuticals i | 1.81 | 205,675 | 2,865,050 | new | |||
| ACRS | aclaris therapeutics inc | 1.79 | 2,458,870 | 2,827,700 | added | 27.57 | ||
| TELA | tela bio inc | 1.77 | 1,110,000 | 2,808,300 | added | 77.42 | ||
